Category: Controlled Substance Prescribing for MD/DO PHYSICIANS, All Specialties, ⚠️Mandatory for FL Physicians⚠️ Category: Controlled Substance Prescribing for MD/DO PHYSICIANS, All Specialties, ⚠️Mandatory for FL Physicians⚠️ (show less)

On March 19, 2018, Gov. Rick Scott signed bill HB 21 into law which includes a variety of measures to combat the opioid crisis. The bill states that each person registered with the United States Drug Enforcement Administration and authorized to prescribe controlled substances shall complete a board-approved two-hour continuing education (CE) course on prescribing controlled substances. The Florida Medical Association (FMA) is approved by the Florida Boards of Medicine to provide this two-hour mandatory requirement for MDs and DOs. Although only DEA-registered prescribers of controlled substances are required to complete this training every two years, all physicians are welcome to complete this course. All CME credit earned will be reported to CE Broker. HB 21 required prescribers to complete this course for the first time no later than January 31, 2019 and then for each subsequent renewal thereafter.
 
CME Objectives:
 After completing this activity, learners will be able to:
 

• Recognize the relevant prescribing laws and rules that govern prescribers of controlled substances in Florida
• Compare and contrast scheduled drugs related to treatment of pain, both acute and chronic nonmalignant pain
• List alternative pharmacologic options, non-pharmacologic methods and procedures, and complementary and alternative treatment options for managing pain
• Apply concepts of SBIRT (screening, brief intervention and referral to treatment) and motivational interviewing within patient encounters  
• Utilize appropriate screening tools such as ORT®, SOAPP-R®, COMM™, UDS, E-FORCSE® and others to identify patients at risk for misuse or who are addicted to controlled substances
• Implement appropriate monitoring and referrals for patients who are prescribed controlled substances
• List appropriate screening and documentation requirements for prescribing controlled substances in patients experiencing pain
• State national recommendations on the safe levels of opioids by morphine milligram dose equivalents and durations of treatment for acute and chronic nonmalignant pain

 
Disclosure:
The planners of this activity have nothing to disclose.
The presenter, Dr. Lenchus disclosed that he is a Consultant for Medline Industries, Inc. This relationship has been mitigated. 
 
Estimated Completion Time: Two Hours
 
Instructions for Earning Credit:
 

• View and listen to the entire recorded presentation. 
• Reflect on the current and best practices discussed and how the information may change your own current practices.
• Complete the online assessment/evaluation form. 

 
Issue Date: December 19, 2024
Expiration Date: December 31, 2025